CHEK1 and ovarian cancer: Importantly, depletion or inhibition of Rad51 dramatically increased the sensitivity of ovarian cancer cells to ATR and Chk1 inhibition, suggesting that HR deficiency and inhibition of ATR/Chk1 pathway can be synthetically lethal [31].